dockets: FDA-2025-P-7432

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id
FDA-2025-P-7432 FDA Requests that FDA declare that Guanfacine Extended-Release Powder for Oral Suspension, 1 mg/mL, is suitable for submission as an ANDA Nonrulemaking 2026-01-20T16:15:24Z 0b000064b91141ce

Links from other tables